Clinical Trial Update: TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH

View source ↗

Summary

The clinical trial 'Transpulmonary Estrogen Gradient and Estrogen Receptors (TYEGER)' for pulmonary arterial hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Pulmonary Arterial Hypertension | Status: WITHDRAWN